Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L F Verdonck

Showing results (11-20 of 129) with videos related to

Pageof 13
Sort By:
Cancer|April 15, 1997
Immunosuppressive therapy for hypoplastic myelodysplastic syndromeD H Biesma, J G van den Tweel, L F Verdonck
Biochemical Pharmacology|April 29, 1994
Protein kinase C is not involved in the cytotoxic action of 1-octadecyl-2-O-methyl-sn-glycerol-3-phosphocholine in HL-60 and K562 cellsE C Heesbeen, L F Verdonck, G E Staal, et al.
Bone Marrow Transplantation|March 8, 2007
Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, risk factors and survivalS Kersting, H A Koomans, R J Hené, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
High-risk multiple myeloma treated with high-dose melphalanH M Lokhorst, O J Meuwissen, L F Verdonck, et al.
Leukemia Research|June 1, 1995
Influence of serum levels on leukemic cell destruction by the ether lipid ET-18-OCH3E C Heesbeen, G Rijksen, H G van Heugten, et al.
Bone Marrow Transplantation|December 7, 2000
No effect of nadroparin prophylaxis in the prevention of central venous catheter (CVC)-associated thrombosis in bone marrow transplant recipientsS W Lagro, L F Verdonck, I H Borel Rinkes, et al.
Leukemia Research|June 10, 1998
Multidrug-resistant acute leukemia cells are responsive to prolonged exposure of daunorubicin: implications for liposome-encapsulated daunorubicinL F Verdonck, H M Lokhorst, D J Roovers, et al.
Bone Marrow Transplantation|September 11, 1998
Oerskovia xanthineolytica: a new pathogen in bone marrow transplantationP Ellerbroek, S Kuipers, M Rozenberg-Arska, et al.
Bone Marrow Transplantation|September 5, 2002
Early infections in adults undergoing matched related and matched unrelated/mismatched donor stem cell transplantation: a comparison of incidenceM G J van Kraaij, L F Verdonck, M Rozenberg-Arska, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1997
A risk-adapted approach with a short course of ganciclovir to prevent cytomegalovirus (CMV) pneumonia in CMV-seropositive recipients of allogeneic bone marrow transplantsL F Verdonck, A W Dekker, M Rozenberg-Arska, et al.
Pageof 13

Showing results (11-20 of 129) with videos related to

Sort By:
Pageof 13
Cancer|April 15, 1997
Immunosuppressive therapy for hypoplastic myelodysplastic syndromeD H Biesma, J G van den Tweel, L F Verdonck
Biochemical Pharmacology|April 29, 1994
Protein kinase C is not involved in the cytotoxic action of 1-octadecyl-2-O-methyl-sn-glycerol-3-phosphocholine in HL-60 and K562 cellsE C Heesbeen, L F Verdonck, G E Staal, et al.
Bone Marrow Transplantation|March 8, 2007
Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, risk factors and survivalS Kersting, H A Koomans, R J Hené, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
High-risk multiple myeloma treated with high-dose melphalanH M Lokhorst, O J Meuwissen, L F Verdonck, et al.
Leukemia Research|June 1, 1995
Influence of serum levels on leukemic cell destruction by the ether lipid ET-18-OCH3E C Heesbeen, G Rijksen, H G van Heugten, et al.
Bone Marrow Transplantation|December 7, 2000
No effect of nadroparin prophylaxis in the prevention of central venous catheter (CVC)-associated thrombosis in bone marrow transplant recipientsS W Lagro, L F Verdonck, I H Borel Rinkes, et al.
Leukemia Research|June 10, 1998
Multidrug-resistant acute leukemia cells are responsive to prolonged exposure of daunorubicin: implications for liposome-encapsulated daunorubicinL F Verdonck, H M Lokhorst, D J Roovers, et al.
Bone Marrow Transplantation|September 11, 1998
Oerskovia xanthineolytica: a new pathogen in bone marrow transplantationP Ellerbroek, S Kuipers, M Rozenberg-Arska, et al.
Bone Marrow Transplantation|September 5, 2002
Early infections in adults undergoing matched related and matched unrelated/mismatched donor stem cell transplantation: a comparison of incidenceM G J van Kraaij, L F Verdonck, M Rozenberg-Arska, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1997
A risk-adapted approach with a short course of ganciclovir to prevent cytomegalovirus (CMV) pneumonia in CMV-seropositive recipients of allogeneic bone marrow transplantsL F Verdonck, A W Dekker, M Rozenberg-Arska, et al.
Pageof 13